Transforming Diabetes Management through Strategic Partnership
In a significant advancement for diabetes care, Hedia and Glooko have joined forces to launch a reliable and accessible solution for bolus insulin dosing. This partnership aims to support individuals with Type 1 and Type 2 diabetes, empowering them with the tools they need to manage their condition more effectively.
What Is Bolus Insulin and Why Is It Important?
Bolus insulin refers to an extra dose taken to manage blood sugar rises, often linked to meals or snacks. Understanding the complexities of insulin dosing can be challenging for patients, especially those without insulin pumps. Typically, individuals may require one unit of insulin to lower blood glucose by about 50 mg/dl, though this can differ from person to person.
The Role of Glooko in Diabetes Management
The Glooko platform allows users to seamlessly share critical diabetes-related data with their healthcare providers. This includes a range of information, such as blood glucose levels, insulin doses, carbohydrate intake, and more. The integration of Hedia's Diabetes Assistant with Glooko's platform significantly simplifies the process of calculating insulin doses for patients, promoting better blood glucose management overall.
Improving Patient Care and Provider Efficiency
This innovative approach not only benefits patients by offering personalized support but also enhances healthcare providers' understanding of their patients' health statuses. With streamlined access to essential data, providers can make informed decisions to optimize care, whether through virtual consultations or in-person visits.
Commitment to Innovation in Diabetes Care
Mike Alvarez, CEO of Glooko, expressed excitement about this collaboration, highlighting their commitment to enhancing diabetes care through innovative solutions. "Our partnership with Hedia enables us to deliver personalized innovations that better the lives of diabetes patients. This reflects our dedication to optimizing management strategies for those who cannot access insulin pumps," he stated.
Hedia's Dedication to Quality
Lars Christian Lund, CEO of Hedia, emphasized the importance of regulatory compliance in their offerings. Hedia has recently attained MDR certification in Europe, ensuring that their technology meets high standards. With a focus on improving the quality of life for individuals with diabetes, Hedia's solutions are grounded in strong clinical evidence, providing necessary support to patients and their care teams.
About Hedia
Hedia is a frontrunner in the digital therapeutics arena for diabetes, dedicated to aiding insulin-dependent patients in managing their conditions. By utilizing various data points, their Diabetes Assistant application generates tailored insulin recommendations, making diabetes management simpler for users.
About Glooko
Glooko’s platform significantly enhances health outcomes for people facing chronic conditions. Their technologies facilitate better connections between patients and healthcare providers, fostering engagement and adherence through digital therapeutics, all while advancing clinical research.
Frequently Asked Questions
What does the new partnership between Hedia and Glooko involve?
The partnership focuses on providing personalized bolus dosing advice to enhance diabetes management for patients using connected health solutions.
How does bolus insulin help diabetes patients?
Bolus insulin is crucial for managing blood sugar levels, especially related to meals, ensuring individuals can control their glucose effectively.
What benefits do patients gain from the Glooko platform?
Patients can share data with healthcare providers, ensuring they receive personalized support and streamlined management of their diabetes.
What is the significance of Hedia's MDR certification?
MDR certification ensures that Hedia's solutions meet high safety and efficacy standards, providing patients confidence in their diabetes management tools.
How can healthcare providers use the Glooko platform?
The Glooko platform offers healthcare providers enhanced visibility into their patients' health, facilitating informed decision-making and better patient outcomes.
